Author:
Banka Radhika,Terrington Dayle,Mishra Eleanor K.
Funder
University of East Anglia
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference21 articles.
1. Taghizadeh N, Fortin M, Tremblay A. US hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient Sample. Chest. 2017;151(4):845–54.
2. Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307(22):2383–9. https://doi.org/10.1001/jama.2012.5535 .
3. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii32–40.
4. Chung CL, Chen YC, Chang SC. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest. 2003;123(4):1188–95. https://doi.org/10.1378/chest.123.4.1188 .
5. •• Mishra EKBBMMD, Clive AO, Wills GH, et al. Randomised controlled trial of Urokinase versus placebo for non-draining malignant pleural effusion. Am J Respir Crit Care Med. 2017; Demonstrates no improvement in dyspnoea relief or pleurodesis success following fibrinolytics for non-draining malignant pleural effusion
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献